References
Kansui Y, Ohtsubo T, Goto K, et al. Association of serum uric acid with blood pressure in Japanese men: cross-sectional study in work-site group. Circ J. 2011;75:2827–32.
Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis. 2009;202:11–7.
Toda A, Ishizaka Y, Tani M, et al. Hyperuricemia is a significant risk factor for the onset of chronic kidney disease. Nephron Clin Pract. 2014;15(126):33–8.
Becker MA, Schumachar HR, Wortmann RL, et al. Febuxostat compared allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353:2450–61.
Halevy S, Ghislain PD, Mockenhaupt M, et al. Allopirinol is common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008;58:25–32.
Fagugli RM, Gentile G, Ferrara G, et al. Acute renal and hepatic failure associated with allopurinol treatment. Clin Nephrol. 2008;70:523–6.
Sánchez-Lozada LG, Tapia E, Soto V, Avila-Casado C, et al. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia. Nephron Physiol. 2008;108:69–78.
Sánchez-Lozada LG, Tapia E, et al. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia. Nephrol Dial Transplant. 2008;23:1179–85.
Omori H, Kawada N, Inoue K, et al. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral obstructive nephropathy. Clin Exp Nephrol. 2012;16:549–56.
Kobayashi S, Ogura M, Hosoya T. Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease. J Clin Pharm Ther. 2013;38(3):258–61.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ohya, M., Shigematsu, T. A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients. Clin Exp Nephrol 18, 835–836 (2014). https://doi.org/10.1007/s10157-014-0989-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-014-0989-7